STAT

MARCH 17, 2025

Belgian anti-trust regulators are probing Roche over concerns that the drug company took steps to delay the entry of biosimilar versions of two of its cancer medicines. In a brief statement , the Belgian Competition Authority alleged that Roche offered financial incentives to hospitals between 2017 and 2020 to deter them from considering competitive bids from other pharmaceutical companies that could supply similar medicines.

Biosimilars 202

Biosimilars Hospitals Pharmaceutical Companies Pharmaceutical Companies 202

PhRMA

MARCH 17, 2025

Half of every dollar spent on medicines goes to entities that don’t make medicine—like pharmacy benefit managers (PBMs) and insurers who are aggressively consolidating their control over health care and hospitals, clinics and for-profit pharmacies in the 340B markup program. As entities in the supply chain that don’t make medicine are increasingly using medicines to subsidize other parts of their business, patients and employers face increasing costs and barriers to accessing c

Hospitals 105

Hospitals 105

STAT

MARCH 17, 2025

In a recent report, the U.S. Federal Trade Commission released an update on patent settlements between brand-name and generic drug makers, but for the first time, mentioned a maneuver used by these companies that may raise a different type of antitrust concern. These settlements can be traced to a law passed 40 years ago that was designed to speed the entry of lower-cost generics to the marketplace.

Drug Pricing 202

Drug Pricing 202

PharmaVoice

MARCH 17, 2025

Even with Big Pharmas pouring billions into the space, the potential of radiopharmaceuticals remains largely untapped.

Drug Development 165

Drug Development 165

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

STAT

MARCH 17, 2025

Harvard Medical School professor Isaac Kohane remembers being asked, when he was a trainee doctor, to diagnose a child with low blood sugar in the intensive care unit. He delivered a beautifully comprehensive list of everything it could possibly be, he recalled — “Mwah!” Then his attending asked him a simple question: “When were the IVs switched?

Medical Schools 237

Medical Schools 237

Pharma Marketing Network

MARCH 17, 2025

Introduction In todays competitive pharmaceutical landscape, marketing strategies must evolve to meet changing customer expectations. Are you still relying on traditional marketing tactics, or have you embraced a more dynamic, omnichannel marketing approach? With healthcare providers (HCPs) and patients engaging across multiple digital and offline touchpoints, pharma brands that fail to adapt risk losing valuable market share.

Diabetes 59

Diabetes 59

The Guardian - Pharmaceutical Industry

MARCH 17, 2025

UK pharma group acquires Belgiums EsoBiotec as it announces EU has approved Imfinzi lung cancer drug Business live latest updates AstraZeneca has struck a $1bn (773m) deal to buy a Belgian biotech company that specialises in cancer immunotherapies, the latest in a string of acquisitions that also yielded positive results for a late-stage rare disease drug on Monday.

Immunity 64

Immunity Immunization 64

PharmaVoice

MARCH 17, 2025

The new $5.3 billion deal with the Swiss pharma giant gives Zealand a significant partner to advance its amylin analog obesity shot and create a new combination product.

130

130

Pharma Times

MARCH 17, 2025

VIDAR-1 trial marks company's clinical-stage debut

125

125

Pharmaceutical Business Review

MARCH 17, 2025

This investigational medicine is stated to be the first ribonucleic acid (RNA) editing development candidate from the companys Oligonucleotide Promoted Editing of RNA (OPERA) platform. Korro Bio chief medical officer Kemi Olugemo said: Receiving orphan drug designation from the FDA underscores the growing need for new treatments for patients living with AATD.

52

52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Pharma Times

MARCH 17, 2025

Collaboration brings remote care to cancer patients

120

120

Putting Patients First Blog

MARCH 17, 2025

Kimberly A. Beer Joins the National Health Council as Senior Vice President, Policy and External Affairs (PDF) Contact For Immediate Release Jennifer Schleman jschleman@nhcouncil.org (WASHINGTON, DC, March 17, 2025) The National Health Council (NHC) welcomes Kimberly A.

52

52

BioPharma Dive

MARCH 17, 2025

Study results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant in treating certain blood cancers.

107

107

Drug Patent Watch

MARCH 17, 2025

The Hidden Costs of Drug Patent Litigation: How to Stay Ahead of the Game As a pharmaceutical professional, you're no stranger to the complexities of drug patent litigation. The stakes are high, and the costs can be astronomical. But what if I told you that there's a way to manage these costs and stay ahead of the game? In today's fast-paced pharmaceutical landscape, patent litigation is an inevitable reality.

Communication 88

Communication 88

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

BioPharma Dive

MARCH 17, 2025

Discover NGS for GxP compliance with full audit trails, operational control and robust data security.

98

98

pharmaphorum

MARCH 17, 2025

Latigo has tapped into investor interest in pain relief medicines with new, non-opioid mechanisms of action, raising $150 million in a Series B

76

76

BioPharma Dive

MARCH 17, 2025

With the right strategy, reaching LPI ahead of schedule isn’t a myth. Learn how some biotech and pharma teams are achieving the impossible.

98

98

The Pharmacist

MARCH 17, 2025

The National Pharmacy Association (NPA) has advised its members in England to reduce their opening hours, as a funding deal for the sector has still not yet been announced. This could see NPA pharmacies give notice from 1 April that they will reduce their opening hours to core contractual minimums. Reduced opening hours could then […] The post NPA tells pharmacies to reduce hours as April looms with no contract yet appeared first on The Pharmacist.

74

74

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

BioPharma Dive

MARCH 17, 2025

The round, which included more than a dozen investment firms, should give the startup enough cash to get late-stage data for its lead candidate.

89

89

European Pharmaceutical Review

MARCH 17, 2025

AstraZeneca has agreed to acquire Belgian biotech EsoBiotec for up to $1 billion. The deal focuses on development of in vivo cell therapies, utilising EsoBiotecs Engineered NanoBody Lentiviral (ENaBL) platform. EsoBiotec will receive an initial payment of $425 million once the deal has closed, plus up to $575 million based on development and regulatory milestones.

Immunity 52

Immunity Immunization 52

pharmaphorum

MARCH 17, 2025

Taiho has reached a deal to buy Swiss biotech Araris, around 18 months after they started collaborating on antibody-drug conjugates for cancer

71

71

BioPharma Dive

MARCH 17, 2025

The British drugmaker is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating cancer as well as autoimmune conditions.

70

70

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharma Marketing Network

MARCH 17, 2025

Table of Contents Understanding the Importance of HCP Engagement in Pharma Marketing Key Marketing Strategies for Pharma Brands to Reach HCPs Optimizing Digital and Paid Media Strategies for Pharma Marketing Measuring Success: Tracking HCP Engagement and ROI Understanding the Importance of HCP Engagement in Pharma Marketing Engaging healthcare professionals (HCPs) effectively is a top priority for pharmaceutical brands.

52

52

Pharmaceutical Technology

MARCH 17, 2025

Taiho is turning its long-time ADC partner into a wholly owned subsidiary with the acquisition.

69

69

Drug Patent Watch

MARCH 17, 2025

Unlock the Secrets to a Successful Generic Drug Launch Are you a pharmaceutical executive looking to bring a generic version of a popular medication to market? Or perhaps you're a healthcare professional interested in understanding the intricacies of generic drug launches? Whatever your role, a successful generic drug launch requires careful planning, strategic execution, and a deep understanding of the regulatory landscape.

Communication 55

Communication 55

Express Pharma

MARCH 17, 2025

mAbTree Biologics has signed an exclusive co-development and commercialisation partnership with Shilpa Biologicals (a fully owned subsidiary of Shilpa Medicare) for its novel biologic asset [a checkpoint inhibitor] for immuno-oncological applications. Under the terms of the strategic agreement, Shilpa Biologicals will support both development including clinical studies as well as long-term commercial supply with GMP manufacturing.

Immunity 65

Immunity Immunization Chemotherapy 65

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

MARCH 17, 2025

Azurity Pharmaceuticals has acquired Covis Group from existing investors, making the latter a wholly owned subsidiary.

64

64

Fuld & Company Blog

MARCH 17, 2025

Competitive intelligence is a powerful tool for navigating uncertainty and staying ahead in a rapidly shifting business landscape. This month, we explore how companies are using CI to drive innovation, improve decision-making, and uncover new growth opportunities. From real-world case studies in our upcoming webinar to key forces shaping the energy sector in 2025, we highlight the insights that matter.

52

52

Pharmaceutical Technology

MARCH 17, 2025

Experts at the 2025 Clinical Trial Supply New England conference will discuss strategies for optimising clinical supply chains.

59

59

Pharmaceutical Commerce

MARCH 17, 2025

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, comments on how he envisions automation in the CAR-T manufacturing space playing a role in improving efficiency, reducing costs, and ultimately, expanding patient access.

59

59

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management